Digitonin enhances the efficacy of carboplatin in liver tumour after intra-arterial administration

Cancer Chemotherapy and Pharmacology

Volumn 40, Issue 5, 1997, Pages 444-448

  Lindnér, Per G ^a   Heath, Dennis ^b   Howell, Stephen B ^b   Naredi, Peter L ^a   Hafström, Larsolof R ^c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Carboplatin; Digitonin; Liver tumour; Tumour growth

Indexed keywords

CARBOPLATIN; DIGITONIN; XENON 133;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; DRUG TUMOR LEVEL; FEMALE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER BIOPSY; LIVER PARENCHYMA; LIVER TUMOR; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBOPLATIN; DETERGENTS; DIGITONIN; FEMALE; HEPATIC ARTERY; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS, EXPERIMENTAL; MALE; ORGAN SIZE; RATS; RATS, INBRED STRAINS;

EID: 0030806425     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050684     Document Type: Article

References (16)

1. Andrews PA, Howell SB (1990) Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2: 35-43
2. Andrews PA, Velury S, Mann SC, Howell SB (1988) cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res 48: 68-73
3. Assem M, Bonvalot S, Beltramo JL, Garrido C, Dimanche-Boitrel MT, Genne P, Bebibou JM, Caillot D, Chauffert B (1994) Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells. Br J Cancer 70: 631-635
4. 135. Microcirc Clin Exp 2: 27-37
5. Carlsson G, Gullberg B, Hafström L (1983) Estimation of liver tumour volume using different formulas - an experimental study in rats. J Cancer Res Clin Oncol 105: 20-23
6. Chen H-SG, Gross JF (1980) Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review responses. Cancer Treat Rep 64: 31-40
7. Elferink F, VanderVijgh WJF, Klein I, Ten Bokkel Huinink WW, Dubbleman R, McVie JG (1988) Pharmacokinetics of carboplatin after intraperitoneal administration. Cancer Chemother Pharmacol 21: 57-60
8. Gale RG, Morris CR, Atkins LM, Smith AB (1973) Binding of an antitumour platinum compound to cells as influenced by physical factors and pharmacologically active agents. Cancer Res 33: 813-818
9. Gately DP, Howell SB (1993) Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer 67: 1171-1176
10. Jekunen AP, Shalinsky DR, Heath DD, Khatibi S, Albright KD, Howell SB (1992) Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane using digitonin in vitro and in vivo (abstract). Proc Am Assoc Cancer Res 33: 419
11. Jekunen AP, Shalinsky DR, Hom DK, Albright KD, Heath D, Howell SB (1993) Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro. Biochem Pharmacol 45: 2079-2085
12. Lutz RJ, Miller DL (1988) Mixing studies during hepatic artery infusion in an in vitro model. Cancer 62: 1066-1073
13. Melvik JE, Pettersen EO, Gordon PB, Seglen PO (1986) Increase in cis-dichlorodiammineplatinum(II) cytotoxicity upon reversible electropermeabilization of the plasma membrane in cultured human NHIK 3025 cells. Eur J Cancer Clin Oncol 22: 1523-1530
14. Oguri S, Sakakibara T, Mase H, Shimizu T, Ishikawa K, Kimura K, Smyth RD (1988) Clinical pharmacokinetics of carboplatin. J Clin Pharmacol 28: 208-215
15. Vercesi AE, Bernardes CF, Hoffman ME, Gadelha FR, Docampo R (1991) Digitonin permeabilization does not affect mitochondrial function and allows the determination of the mitochondrial membrane potential of Trypanosoma cruzi in situ. J Biol Chem 266: 14431-14434
16. Weaver JC (1993) Electroporation: a general phenomenon for manipulating cells and tissues. J Cell Biochem 51: 426-435